EL-PFDD Meeting: Cardiac Late Effects for Survivors

The second childhood cancer-focused externally-led patient focused drug development workshop for the FDA spotlighted the burden of lifelong cardiac late effects in pediatric cancer survivors. Personal testimony detailed the depth and spectrum of this impact. Learn more by reviewing the recording and Voice of the Patient Report.